Invention Grant
- Patent Title: Crystal form and salt form of and preparation method for tyrosine kinase inhibitor
-
Application No.: US16337874Application Date: 2017-09-29
-
Publication No.: US10766862B2Publication Date: 2020-09-08
- Inventor: Chaofeng Long , Zhengxia Chen , Xiaoxin Chen , Yang Zhang , Zhuowei Liu , Shuhui Chen , Jian Li
- Applicant: GUANGDONG RAYNOVENT BIOTECH CO., LTD.
- Applicant Address: CN Shenzhen
- Assignee: Guangdong Raynovent Biotech Co., Ltd.
- Current Assignee: Guangdong Raynovent Biotech Co., Ltd.
- Current Assignee Address: CN Shenzhen
- Agency: D'Ambrosio & Menon, PLLC
- Agent Usha Menon
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@28bc3bf8
- International Application: PCT/CN2017/104260 WO 20170929
- International Announcement: WO2018/059534 WO 20180405
- Main IPC: C07D215/233
- IPC: C07D215/233
Abstract:
Disclosed are a crystal form and a salt form of and a preparation method for a tyrosine kinase inhibitor.
Public/Granted literature
- US20200024235A1 CRYSTAL FORM AND SALT FORM OF AND PREPARATION METHOD FOR TYROSINE KINASE INHIBITOR Public/Granted day:2020-01-23
Information query
